Sciospec Success Case: Impedance Spectroscopy for Early Hemorrhage Monitoring
Sciospec Success Case: Impedance Spectroscopy for Early Hemorrhage Monitoring
Source:https://sciospec.com/portfolio/monitoring-early-blood-loss-with-impedance-spectroscopy/
Sciospec Product Used: ISX-3 (Electrical Impedance Analyzer)
Year: 2024
Research Objective:
To explore whether advanced monitoring methods, such as Electrical Impedance Spectroscopy (EIS) and Electrical Impedance Tomography (EIT), can detect early signs of internal blood volume loss (hypovolemia) before traditional vital signs.
Methodology:
Model: Human study using the Lower Body Negative Pressure (LBNP) model to simulate hypovolemia.
Technology: Sciospec's ISX-3 system was the central component, providing non-invasive, high-resolution measurements of thoracic and abdominal impedance.
Comparison: Comparison between impedance metrics and traditional vital signs (heart rate, blood pressure).
Key Result:
Thoracic impedance metrics, measured by EIS and EIT, were more sensitive than traditional vital signs in identifying early-stage hypovolemia. Impedance deviations provided earlier warnings.
Implication/Impact:
The Sciospec ISX-3 technology enabled precise and flexible signal acquisition, capturing physiological changes before they manifested as clinical symptoms. This positions EIS as a powerful tool for non-invasive hemodynamic monitoring and the development of predictive diagnostics, especially in critical care environments.
Connection with Operational Excellence (Allum Corp):
This case demonstrates Operational Excellence in healthcare, focused on:
Forecasting and Prevention: The ability to detect physiological changes before symptoms enables faster and preventive interventions, optimizing patient care.
High Resolution and Stability: The ISX-3 offers the precision and signal stability required to capture subtle but critical deviations in the human body, ensuring data reliability.
Scalability: The ISX-3 platform supports up to 64 channels with modular multiplexers, allowing bench research to scale to larger clinical trials and multi-site monitoring—a core principle of excellence in R&D project management.
